Topic Highlight
Copyright ©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Jul 21, 2014; 20(27): 8783-8789
Published online Jul 21, 2014. doi: 10.3748/wjg.v20.i27.8783
Table 1 Summary of studies investigating colorectal cancer as a risk factor in patients with concurrent primary sclerosing cholangitis and inflammatory bowel disease
Ref.LocationIBD-PSC patients (n)Colorectal neoplasms (n)Matched controls?Study typeIs IBD-PSC a risk for CRC?
[24]The NetherlandsIBD (126)CRC (16)NoRetrospectiveYes
[9]BelgiumIBD (107)CRC (10)NoRetrospectiveYes
[12]SwedenIBD (152)CRC/Dys (3)NoRetrospectiveNo
[31]GermanyIBD (120)CRC (7)NoProspectiveOnly with dominant stenosis
[28]ArgentinaUC (39)CRC (7)YesProspectiveYes
[30]United StatesUC (50)N/SYesRetrospectiveNo
[32]SwedenCD (28)CRC/Dys (9)YesRetrospectiveYes
[33]United KingdomCD (35)Dys (1)NoRetrospectiveNo